169 related articles for article (PubMed ID: 16247041)
1. Predictors of major neurologic improvement after thrombolysis in acute stroke.
Saposnik G; Di Legge S; Webster F; Hachinski V
Neurology; 2005 Oct; 65(8):1169-74. PubMed ID: 16247041
[TBL] [Abstract][Full Text] [Related]
2. Lack of improvement in patients with acute stroke after treatment with thrombolytic therapy: predictors and association with outcome.
Saposnik G; Young B; Silver B; Di Legge S; Webster F; Beletsky V; Jain V; Nilanont Y; Hachinski V
JAMA; 2004 Oct; 292(15):1839-44. PubMed ID: 15494581
[TBL] [Abstract][Full Text] [Related]
3. Predictors of major neurological improvement after intravenous thrombolysis in acute ischemic stroke: a hospital-based study from south India.
Boddu DB; Srinivasarao Bandaru VC; Reddy PG; Madhusudan M; Rukmini MK; Suryaprabha T; Jabeen SA; Suvarna A; Jayalakshmi SS; Meena AK; Borgohain R; Kaul S
Neurol India; 2010; 58(3):403-6. PubMed ID: 20644268
[TBL] [Abstract][Full Text] [Related]
4. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry.
Mori M; Naganuma M; Okada Y; Hasegawa Y; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Kario K; Okuda S; Koga M; Minematsu K; Toyoda K
Cerebrovasc Dis; 2012; 34(2):140-6. PubMed ID: 22854333
[TBL] [Abstract][Full Text] [Related]
5. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH
JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451
[TBL] [Abstract][Full Text] [Related]
6. Early neurologic improvement based on the National Institutes of Health Stroke Scale score predicts favorable outcome within 30 minutes after undergoing intravenous recombinant tissue plasminogen activator therapy.
Takagi T; Kato T; Sakai H; Nishimura Y
J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):69-74. PubMed ID: 23164483
[TBL] [Abstract][Full Text] [Related]
7. Optimizing discharge planning: clinical predictors of longer stay after recombinant tissue plasminogen activator for acute stroke.
Saposnik G; Webster F; O'Callaghan C; Hachinski V
Stroke; 2005 Jan; 36(1):147-50. PubMed ID: 15569861
[TBL] [Abstract][Full Text] [Related]
8. Time-dependence of NIHSS in predicting functional outcome of patients with acute ischemic stroke treated with intravenous thrombolysis.
Wu Z; Zeng M; Li C; Qiu H; Feng H; Xu X; Zhang H; Wu J
Postgrad Med J; 2019 Apr; 95(1122):181-186. PubMed ID: 30975729
[TBL] [Abstract][Full Text] [Related]
9. Impact of admission hyperglycemia on stroke outcome after thrombolysis: risk stratification in relation to time to reperfusion.
Alvarez-Sabín J; Molina CA; Ribó M; Arenillas JF; Montaner J; Huertas R; Santamarina E; Rubiera M
Stroke; 2004 Nov; 35(11):2493-8. PubMed ID: 15472110
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing clinical outcomes of acute ischemic stroke treated with intravenous recombinant tissue plasminogen activator.
Huang YH; Zhuo ST; Chen YF; Li MM; Lin YY; Yang ML; Chen ZJ; Cai RW
Chin Med J (Engl); 2013; 126(24):4685-90. PubMed ID: 24342312
[TBL] [Abstract][Full Text] [Related]
11. Comparison of acute nonthrombolytic and thrombolytic treatments in ischemic stroke patients 80 years or older.
Zacharatos H; Hassan AE; Vazquez G; Hussein HM; Rodriguez GJ; Suri MF; Lakshminarayan K; Ezzeddine MA; Qureshi AI
Am J Emerg Med; 2012 Jan; 30(1):158-64. PubMed ID: 21247724
[TBL] [Abstract][Full Text] [Related]
12. Improving the predictive accuracy of recanalization on stroke outcome in patients treated with tissue plasminogen activator.
Molina CA; Alexandrov AV; Demchuk AM; Saqqur M; Uchino K; Alvarez-Sabín J;
Stroke; 2004 Jan; 35(1):151-6. PubMed ID: 14671245
[TBL] [Abstract][Full Text] [Related]
13. Is the benefit of early recanalization sustained at 3 months? A prospective cohort study.
Labiche LA; Al-Senani F; Wojner AW; Grotta JC; Malkoff M; Alexandrov AV
Stroke; 2003 Mar; 34(3):695-8. PubMed ID: 12624293
[TBL] [Abstract][Full Text] [Related]
14. Rapidly improving stroke symptoms: a pilot, prospective study.
Balucani C; Bianchi R; Ramkishun C; Weedon J; Law S; Szarek M; Rojas-Soto D; Tariq S; Levine SR
J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1211-6. PubMed ID: 25869774
[TBL] [Abstract][Full Text] [Related]
15. Neglecting the difference: does right or left matter in stroke outcome after thrombolysis?
Di Legge S; Saposnik G; Nilanont Y; Hachinski V
Stroke; 2006 Aug; 37(8):2066-9. PubMed ID: 16794212
[TBL] [Abstract][Full Text] [Related]
16. Dramatic recovery after IV thrombolysis in anterior circulation ischemic stroke: predictive factors and prognosis.
Rocha J; Pinho J; Varanda S; Amorim J; Rocha J; Fontes JR; Maré R; Ferreira C
Clin Neurol Neurosurg; 2014 Oct; 125():19-23. PubMed ID: 25080045
[TBL] [Abstract][Full Text] [Related]
17. Predicting major neurological improvement with intravenous recombinant tissue plasminogen activator treatment of stroke.
Brown DL; Johnston KC; Wagner DP; Haley EC
Stroke; 2004 Jan; 35(1):147-50. PubMed ID: 14657446
[TBL] [Abstract][Full Text] [Related]
18. Simple clinical predictors of stroke outcome based on National Institutes of Health Stroke scale score during 1-h recombinant tissue-type plasminogen activator infusion.
Osaki M; Miyashita F; Koga M; Fukuda M; Shigehatake Y; Nagatsuka K; Minematsu K; Toyoda K
Eur J Neurol; 2014 Mar; 21(3):411-8. PubMed ID: 24200315
[TBL] [Abstract][Full Text] [Related]
19. A simple clinical and MRI scale to predict good outcome in t-PA patients.
Kimura K; Sakamoto Y; Iguchi Y; Shibazaki K; Watanabe M; Aoki J; Inoue T; Uemura J
Neurol Res; 2011 Dec; 33(10):1038-43. PubMed ID: 22196756
[TBL] [Abstract][Full Text] [Related]
20. Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke.
Roveri L; La Gioia S; Ghidinelli C; Anzalone N; De Filippis C; Comi G
J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):703-8. PubMed ID: 22133742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
